VRCA - Verrica Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VRCA is currently covered by 5 analysts with an average price target of $7.52. This is a potential upside of $6.86 (1039.39%) from yesterday's end of day stock price of $0.66.

Verrica Pharmaceuticals's activity chart (see below) currently has 36 price targets and 49 ratings on display. The stock rating distribution of VRCA is 8% HOLD and 92% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 8.93% with an average time for these price targets to be met of 46.71 days.

Highest price target for VRCA is $2, Lowest price target is $2, average price target is $7.52.

Most recent stock forecast was given by OREN LIVNAT from HC WAINWRIGHT on 06-Nov-2024. First documented stock forecast 21-Feb-2019.

Currently out of the existing stock ratings of VRCA, 2 are a HOLD (8%), 23 are a BUY (92%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$14

3 months 1 days ago
(06-Nov-2024)

0/13 (0%)

$4.51 (47.52%)

Hold

$12

3 months 2 days ago
(05-Nov-2024)

3/12 (25%)

$10.55 (727.59%)

169

Buy

$2

$0.99 (98.02%)

$11

3 months 2 days ago
(05-Nov-2024)

1/8 (12.5%)

$1.14 (132.56%)

79

Buy

$10

$8.99 (890.10%)

$10

1 years 1 months 23 days ago
(15-Dec-2023)

0/2 (0%)

$3.91 (64.20%)

Buy

$14

$12.99 (1286.14%)

$4

1 years 6 months 13 days ago
(25-Jul-2023)

1/4 (25%)

$8.68 (163.16%)

79

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VRCA (Verrica Pharmaceuticals) average time for price targets to be met?

On average it took 46.71 days on average for the stock forecasts to be realized with a an average price target met ratio 8.93

Which analyst has the current highest performing score on VRCA (Verrica Pharmaceuticals) with a proven track record?

SERGE BELANGER

Which analyst has the current lower performing score on VRCA (Verrica Pharmaceuticals) with a proven track record?

GLEN SANTANGELO

Which analyst has the most public recommendations on VRCA (Verrica Pharmaceuticals)?

Serge Belanger works at NEEDHAM and has 32 price targets and 26 ratings on VRCA

Which analyst is the currently most bullish on VRCA (Verrica Pharmaceuticals)?

Kemp Dolliver with highest potential upside - $16.47

Which analyst is the currently most reserved on VRCA (Verrica Pharmaceuticals)?

Serge Belanger with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?